Taffic Tablets Bictegravir 50mg

Description

Taffic Tablets, containing Bictegravir 50mg, Emtricitabine 200mg, and Tenofovir Alafenamide 25mg, are a prescribed medication designated for managing HIV-1 infection under the supervision of a medical professional. This fixed-dose combination functions as an antiretroviral medicine to combat the Human Immunodeficiency Virus (HIV) linked with Acquired Immunodeficiency Syndrome (AIDS).

Indication:
Taffic Tablets (Bictegravir 50mg, Emtricitabine 200mg, Tenofovir Alafenamide 25mg) are primarily indicated for adult patients diagnosed with HIV-1 disease. The formulation comprises three key components:

Emtricitabine (200 mg)
Bictegravir (50mg)
Tenofovir Alafenamide (25 mg)
Administration and Dosage:
These tablets are recommended for adult patients with HIV-1 infection. The prescribed dosage is one tablet taken orally once daily, with or without meals. Uninfected adults may take a single dose of one tablet for pre-exposure prophylaxis.

Common Side Effects:
Some common side effects associated with Taffic Tablets include:

Fatigue
Headache
Abnormal dreams
Nausea
Insomnia
Dizziness
Diarrhea

Precautions:
Caution is advised when consuming Taffic Tablets, as certain adverse effects may arise during therapy. Discontinuation of antiretroviral therapy may lead to complications such as hepatomegaly, serious exacerbation of HBV, immune reconstitution syndrome, lactic acidosis, and renal toxicity. Adherence to national guidelines is essential to prevent transmission.

Uses:
Taffic Tablets are effective in treating HIV-1 infection in adults with no prior history of antiretroviral treatment. The combination of Tenofovir Alafenamide, Bictegravir, and Emtricitabine exhibits high antiviral efficacy, establishing a favorable safety profile among HIV-infected individuals. The medication prevents HIV multiplication, reduces viral levels in the blood, and safeguards patients from developing HIV-related diseases.

Duration of Use:
These tablets should be taken once daily with water before or after a meal, following the prescribed period recommended by the doctor. Continuous usage is vital to monitor the patient’s condition and avoid the risk of HIV resistance. Discontinuing the medication midway may diminish its efficacy.

Missed Dose:
In the event of a missed dose, take the medication as soon as remembered, unless it is close to the next scheduled dose. Skipping the missed dose is advisable to prevent a double dose.

Storage:
Store Taffic Tablets below 25 degrees Celsius in a cool, dry place, shielded from direct sunlight and moisture. It is essential to keep the medication in optimal conditions to maintain its effectiveness.